Takeda Pharmaceutical (TAK) EV to EBITDA (2018 - 2026)
Takeda Pharmaceutical's (TAK) EV to EBITDA was -0.33 for the quarter ended Jun 30, 2026, compared with -0.19 a year earlier.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) EV to EBITDA (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Takeda Pharmaceutical's EV to EBITDA came in at -2.28; for the year ended Mar 31, 2026, it came in at -0.87.
- By year, EV to EBITDA came in at -0.37 in the year ended Mar 31, 2025, -0.62 in the year ended Mar 31, 2024, -0.70 in the year ended Mar 31, 2023 and -0.93 in the year ended Mar 31, 2022.
- Five-year quarterly EV to EBITDA spans a low of -0.54 in the quarter ended Jun 30, 2022 and a high of -0.12 in the quarter ended Dec 31, 2023.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -0.36 (quarter ended Mar 31, 2026), -0.43 (quarter ended Dec 31, 2025) and -0.38 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Takeda Pharmaceutical | 62.77 Bn | 39.13 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.23 |
| Mar 31, 2026 | 7.31 |
| Dec 31, 2025 | 5.59 |
| Sep 30, 2025 | 4.02 |
| Jun 30, 2025 | 4.53 |
| Mar 31, 2025 | 4.65 |
| Dec 31, 2024 | 3.80 |
| Sep 30, 2024 | 3.49 |
| Jun 30, 2024 | 3.18 |
| Mar 31, 2024 | 3.78 |
| Dec 31, 2023 | 3.79 |
| Sep 30, 2023 | 3.95 |
| Jun 30, 2023 | 4.93 |
| Mar 31, 2023 | 5.25 |
| Dec 31, 2022 | 4.17 |
| Sep 30, 2022 | 2.92 |
| Jun 30, 2022 | 2.88 |
| Mar 31, 2022 | 2.85 |
| Jun 30, 2021 | 3.83 |
| Mar 31, 2021 | 4.41 |
API Access
Takeda Pharmaceutical EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();